Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a public health crisis over the last two years. Monoclonal antibody (mAb)-based therapeutics against the spike (S) protein have been shown to be effective treatments for SARS-CoV-2 infection, especially the original viral strain...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Collin Jugler, Haiyan Sun, Francisca Grill, Karen Kibler, Adrian Esqueda, Huafang Lai, Yize Li, Douglas Lake, Qiang Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2022-05-01
coleção:	Vaccines
Assuntos:	SARS-CoV-2 COVID-19 monoclonal antibody (mAb) plant-made antibody antibody cocktail neutralization synergy
Acesso em linha:	https://www.mdpi.com/2076-393X/10/5/772
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!